Reduced speech-in-noise intelligibility is one of the main difficulties experienced by children with auditory processing disorder (APD). Previous studies have established a relationship between the function of the medial olivocochlear system (MOCS) and reduced inhibition of otoacoustic emissions (OAE) in children with APD. This study measured spontaneous OAE (SOAE) in 27 children with reduced speech-in-noise intelligibility, and those of a control group matched by gender and age. A significantly higher prevalence of SOAE was found: 85% of the study group presented SOAE, 44% in the control group. An abnormally functioning MOCS with reduced inhibition could lead to an increase in SOAE. Identifying a higher prevalence and number of SOAE may be a helpful objective mean to include in an APD diagnosis test battery.

1.
American Speech-Language-Hearing Association: Central auditory processing: current status of research and implications for clinical practice. Task Force on Central Auditory Processing Consensus Development. Am J Audiol 1996;5:41–54.
2.
Bamiou DE, Musiek FE, Luxon LM: Aetiology and clinical presentations of auditory processing disorder: a review. Arch Dis Child 2001;85:361–365.
3.
Berlin CI, Hood LJ, Cecola RP, Jackson DF, Szabo P: Does type I afferent neuron dysfunction reveal itself through lack of efferent suppression? Hear Res 1993;65:40–50.
4.
Bray PJ: Click Evoked Otoacoustic Emissions and the Development of a Clinical Otoacoustic Hearing Test Instrument; PhD diss, London University 1989.
5.
Burns EM, Arehart KH, Campbell SL: Prevalence of spontaneous otoacoustic emissions in neonates. J Acoust Soc Am 1992;91:1571–1575.
6.
Chermak GD: Deciphering auditory processing disorders in children. Otolaryngol Clin North Am 2002;35:733–749.
7.
Chilla R, Gabriel P, Kodzielski P, Bänsch D, Kabas M: Der Göttinger Kindersprachverständnistest I: Sprachaudiometrie des «Kindergarten»- und retardierten Kindes mit einem Einsilber-Bildertest. HNO 1976;24:342–346.
8.
Collet L, Kemp DT, Veuillet E, Duclaux R, Moulin A, Morgon A: Effect of contralateral auditory stimuli on active cochlear micro-mechanical properties in human subjects. Hear Res 1990;43:251–261.
9.
Collet L, Veillet E, Bene J, Morgan A: Effects of contralateral white noise on click-evoked emissions in normal and sensorineural ears: towards an exploration of the medial olivocochlear system. Audiology 1992;31:1–7.
10.
Drexl M, Henke J, Kössl M: Isoflurane increases amplitude and incidence of evoked and spontaneous otoacoustic emissions. Hear Res 2004;194:135–142.
11.
Esser G: Differenzierung von Schallempfindungsstörungen, Habilitationsschrift. Düsseldorf, 1976.
12.
Feldmann H: Dichotischer Diskriminationstest, eine neue Methode zur Diagnostik zentraler Hörstörungen. Arch Ohren-Nasen-Kehlkopfheilkde 1965;184:294.
13.
Gabriel P, Chilla R, Kiese C, Kabas M, Bänsch D: Der Göttinger Kindersprachverständnistest II: Sprachaudiometrie des Vorschulkindes mit einem Einsilben-Bildtest. HNO 1976;24:399–402.
14.
Giraud AL, Collet L, Chery-Croze S, Magnan J, Chays A: Evidence of medial olivocochlear involvement in contralateral suppression of otoacoustic emissions. Brain Res 1995;705:15–23.
15.
Giraud AL, Garnier S, Micheyl C, Lina G, Chays A, Chery-Croze S: Auditory efferents involved in speech-in-noise intelligibility. Neuroreport 1997;8:1779–1783.
16.
Guinan J: Olivocochlear efferents: anatomy, physiology, function, and measurement of efferent effects in humans. Ear Hear 2006;27:589–607.
17.
Hahlbrock KH: Sprachaudiometrie: Grundlagen und praktische Anwendung einer Sprachaudiometrie für das deutsche Sprachgebiet. Stuttgart, Thieme, 1957.
18.
Hahlbrock KH: Kritische Betrachtungen und vergleichende Untersuchungen der Schubertschen und Freiburger Sprachteste. Z Laryngol Rhinol Otol 1960;39:100.
19.
Kakigi A, Hirakawa H, Mount RJ, Harrison v. R: The effects of crossed olivocochlear bundle section on transient evoked otoacoustic emissions. Hear Res 1997;110:34–38.
20.
Kemp DT, Bray P, Alexander L, Brown AM: Acoustic emission cochleography practical aspects; in Cianfrone G, Grandori F (eds): Cochlear Mechanics and Otoacoustic Emissions. Scand Audiol 1986;25(suppl):71–96.
21.
Khalfa S, Morlet T, Micheyl C, Morgan A, Collet L: Evidence of peripheral hearing asymmetry in humans: clinical implications. Acta Otolaryngol 1997;117:192–196.
22.
Kumar UA, Vanaja CS: Functioning of olivocochlear bundle and speech perception in noise. Ear Hear 2004;25:142–146.
23.
Kuroda T: Clinical investigation on spontaneous emission (SOAE) in 447 ears. Auris Nasus Larynx 2007;34:29–38.
24.
Lamprecht-Dinnesen A, Pohl M, Hartmann S, Heinecke A, Ahrens S, Müller E, Riebandt M: Effects of age, gender and ear side an SOAE parameters in infancy and childhood. Audiol Neurootol 1998;3:386–401.
25.
Matulat P, Lamprecht-Dinnesen A: Münsteraner Untersuchungskonzept bei Verdacht auf zentral-auditive Verarbeitungsstörungen. Z Dialektol Ling 2000;107:109–114.
26.
McFadden D: A speculation about parallel ear asymmetries and sex differences in sensitivity and otoacoustic emissions. Hear Res 1993;68:143–151.
27.
Micheyl C, Morlet T, Giraud AL, Collet L, Morgon A: Contralateral suppression of evoked otoacoustic emissions and detection of a multi-tone complex in noise. Acta Otolaryngol 1995;115:178–182.
28.
Morlet T, Lapillonne A, Ferber C, Duclaux R, Sann L, Putet G, Salle B, Collet L: Spontaneous otoacoustic emissions in preterm neonates: prevalence and gender effects. Hear Res 1995;90:44–54.
29.
Mott JB, Norton SJ, Neely ST, Warr WB: Changes in spontaneous otoacoustic emissions produced by acoustic stimulation of the contralateral ear. Hear Res 1989;38:229–242.
30.
Moulin A, Collet L, Duclaux R: Contralateral auditory stimulation alters acoustic distortion products in humans. Hear Res 1993a;65:193–210.
31.
Moulin A, Collet L, Veuillet E, Morgon A: Interrelations between transiently evoked otoacoustic emissions, spontaneous otoacoustic emissions and acoustic distortion products in normally hearing subjects. Hear Res 1993b;65:216–233.
32.
Muchnik C, Roth DA-E, Othman-Jebara R, Putter-Katz H, Shabtai EL, Hildesheimer M: Reduced medial olivocochlear bundle system function in children with auditory processing disorders. Audiol Neurootol 2004;9:107–114.
33.
Nobili R, Vetesnik A, Turicchia L, Mammano F: Otoacoustic emissions from residual oscillations of the cochlear basilar membrane in human ear model. J Assoc Res Otolaryngol 2004;5:349–359.
34.
Norton SJ, Mott JB, Champlin CA: Behavior of spontaneous otoacoustic emissions following intense ipsilateral acoustic stimulation. Hear Res 1989;38:243–258.
35.
Probst R: Otoacoustic emissions: an overview. Adv Otorhinolaryngol 1990;44:1–19.
36.
Rabinowitz WM, Widin GP: Interaction of spontaneous oto-acoustic emissions and external sounds. J Acoust Soc Am 1984;76:1713–1720.
37.
Sanches SGG, Carvallo RM: Contralateral suppression of transient evoked otoacoustic emissions in children with auditory processing disorder. Audiol Neurootol 2006;11:366–372.
38.
Shera CA: Mammalian spontaneous otoacoustic emissions are amplitude stabilized cochlear standing waves. J Acoust Soc Am 2003;114:244–262.
39.
Strickland EA, Burns EM, Tubis A: Incidence of spontaneous otoacoustic emissions in children and infants. J Acoust Soc Am 1985;78:931–935.
40.
Uttenweiler V: Dichotischer Diskriminationstest für Kinder. Sprache-Stimme-Gehör 1980;4:107.
41.
Veuillet E, Collet L, Duclaux R: Effect of contralateral acoustic stimulation on active cochlear micromechanical properties in human subjects: dependence on stimulus variables. J Neurophysiol 1991;65:724–735.
42.
Wable J, Collet L: Can synchronized otoacoustic emissions really be attributed to SOAE’s? Hear Res 1994;80:141–145.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.